Published in J Allergy Clin Immunol on February 03, 2016
Advancing our understanding of infant bronchiolitis through phenotyping and endotyping: clinical and molecular approaches. Expert Rev Respir Med (2016) 0.80
Using Periostin as a Biomarker in the Treatment of Asthma. Allergy Asthma Immunol Res (2016) 0.79
Mucosal-associated invariant T cells in autoimmunity, immune-mediated diseases and airways disease. Immunology (2016) 0.78
Cluster analysis of sputum cytokine-high profiles reveals diversity in T(h)2-high asthma patients. Respir Res (2017) 0.75
Biomarkers for the Phenotyping and Monitoring of Asthma in Children. Curr Treat Options Allergy (2016) 0.75
Therapeutic interventions in severe asthma. World Allergy Organ J (2016) 0.75
RAGE deficiency predisposes mice to virus-induced paucigranulocytic asthma. Elife (2017) 0.75
Topological methods for genomics: present and future directions. Curr Opin Syst Biol (2016) 0.75
Periostin in inflammation and allergy. Cell Mol Life Sci (2017) 0.75
Asthma Endotypes and an Overview of Targeted Therapy for Asthma. Front Med (Lausanne) (2017) 0.75
Airway and serum biochemical correlates of refractory neutrophilic asthma. J Allergy Clin Immunol (2017) 0.75
MMP-1 Activation Contributes to Airway Smooth Muscle Growth and Asthma Severity. Am J Respir Crit Care Med (2016) 0.75
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
The hospital anxiety and depression scale. Acta Psychiatr Scand (1983) 121.58
Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science (1997) 8.19
Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med (2009) 7.17
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol (2007) 6.33
A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med (2007) 6.02
Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med (2008) 5.80
Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax (1992) 5.37
Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med (2008) 4.58
MMP12, lung function, and COPD in high-risk populations. N Engl J Med (2009) 3.96
University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope (1984) 3.80
Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet (2008) 3.71
Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg (2002) 3.67
Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol (2011) 3.35
Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell (1992) 2.75
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med (2015) 2.71
Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology (2006) 2.67
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration (2011) 1.78
Measuring asthma control. Clinic questionnaire or daily diary? Am J Respir Crit Care Med (2000) 1.52
Extracting insights from the shape of complex data using topology. Sci Rep (2013) 1.40
Animal models for chronic obstructive pulmonary disease: age of klotho and marlboro mice. Am J Respir Cell Mol Biol (2000) 1.28
Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data. J Allergy Clin Immunol (2014) 1.24
Ten-year follow-up of cluster-based asthma phenotypes in adults. A pooled analysis of three cohorts. Am J Respir Crit Care Med (2013) 1.10
Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms. J Allergy Clin Immunol (2015) 1.07
Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity. J Allergy Clin Immunol (2012) 1.01
YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK and ERK) and NF-κB pathways, causing bronchial smooth muscle proliferation and migration. J Immunol (2012) 1.00
Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus. Am J Respir Crit Care Med (1999) 0.97
Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease. Respiration (2011) 0.96
Neutrophils as a novel source of eosinophil cationic protein in IgE-mediated processes. J Immunol (2007) 0.94
Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. J Immunol (1995) 0.92
Matrix metalloproteinase-12 is a therapeutic target for asthma in children and young adults. J Allergy Clin Immunol (2010) 0.89
Matrix metalloproteinase 8 contributes to solubilization of IL-13 receptor alpha2 in vivo. J Allergy Clin Immunol (2008) 0.88
Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults. J Allergy Clin Immunol (2015) 0.87
Genetic variation in chitinase 3-like 1 (CHI3L1) contributes to asthma severity and airway expression of YKL-40. J Allergy Clin Immunol (2015) 0.85
Statistical cluster analysis of the British Thoracic Society Severe refractory Asthma Registry: clinical outcomes and phenotype stability. PLoS One (2014) 0.84
Role of Chitinase 3-Like-1 in Interleukin-18-Induced Pulmonary Type 1, Type 2, and Type 17 Inflammation; Alveolar Destruction; and Airway Fibrosis in the Murine Lung. Am J Respir Cell Mol Biol (2015) 0.81
Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms. J Allergy Clin Immunol (2015) 1.07
Periostin in allergic inflammation. Allergol Int (2014) 1.03
Periostin controls keratinocyte proliferation and differentiation by interacting with the paracrine IL-1α/IL-6 loop. J Invest Dermatol (2013) 0.91
Periostin contributes to epidermal hyperplasia in psoriasis common to atopic dermatitis. Allergol Int (2014) 0.91
Association of serum periostin with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2014) 0.87
Periostin Is a Key Niche Component for Wound Metastasis of Melanoma. PLoS One (2015) 0.85
Integrating longitudinal information on pulmonary function and inflammation using asthma phenotypes. J Allergy Clin Immunol (2014) 0.81
Phenotype of asthma related with high serum periostin levels. Allergol Int (2014) 0.79
Recent developments regarding periostin in bronchial asthma. Allergol Int (2015) 0.78
Reversal of New-Onset Type 1 Diabetes With an Agonistic TLR4/MD-2 Monoclonal Antibody. Diabetes (2015) 0.77
No increase in the serum periostin level is detected in elementary school-age children with allergic diseases. Allergol Int (2015) 0.77
Expressions and roles of periostin in otolaryngological diseases. Allergol Int (2014) 0.77
The usefulness of combined measurements of squamous cell carcinoma antigens 1 and 2 in diagnosing atopic dermatitis. Ann Clin Biochem (2012) 0.77
Periostin in the bronchial lavage fluid of asthma patients. Allergol Int (2015) 0.77
The potential for repositioning antithyroid agents as antiasthma drugs. J Allergy Clin Immunol (2016) 0.76
Periostin as a biomarker for the diagnosis of pediatric asthma. Pediatr Allergy Immunol (2016) 0.76
The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases. J Allergy Clin Immunol (2016) 0.76
Staphylococcus aureus enterotoxin sensitization involvement and its association with the CysLTR1 variant in different asthma phenotypes. Ann Allergy Asthma Immunol (2016) 0.75
Circulating activated innate lymphoid cells and mucosal-associated invariant T cells are associated with airflow limitation in patients with asthma. Allergol Int (2016) 0.75
Clinical implication of the serum periostin level for differentiating phenotypes of NSAID hypersensitivity. Allergol Int (2016) 0.75
Serum periostin is associated with body mass index and allergic rhinitis in healthy and asthmatic subjects. Allergol Int (2017) 0.75
Up-regulation of serum periostin and squamous cell carcinoma antigen levels in infants with acute bronchitis due to respiratory syncytial virus. Allergol Int (2017) 0.75
Periostin in Allergic Inflammation. Allergol Int (2015) 0.75